Alzheimer’s disease: the new promise.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 22754953.
- Also identified by PMC identifier 3314477.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Clinical vignette: A 59-year-old aeronautical engineer is referred to you for evaluation because of increasing difficulty with job performance over the last several years. Difficulty managing home finances, getting lost driving, and forgetting appointments have become common. Previously outgoing, he is now depressed and irritable. After appropriate neurologic assessment, including brain imaging and metabolic studies, you make the diagnosis of Alzheimer’s dementia and are asked by the patient’s family what treatment is available.
Medical subject headings
- Alzheimer Disease
- Amyloid beta-Peptides
- Brain
- Cognition Disorders
- Hippocampus
- Hypoglycemic Agents
- Insulin
- Insulin Receptor Substrate Proteins
- Insulin Resistance
- Insulin-Like Growth Factor I
- Peptides
- Venoms